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Metastasis to the oral cavity are rare, representing only 1% of all oral malignancies, and originate from various sites 
such as the breast, prostate, lung and kidney. Clinically, they can simulate reactive and inflammatory lesions com-
mon in the oral cavity, and the clinical and microscopic diagnosis of these metastasis is a challenge. In this article, 
we report two new cases of esophageal and lung metastasis to oral tissues, highlighting their clinical characteristics 
and the process of diagnostic elucidation. We emphasize the importance for clinicians to consider the possibility of 
metastatic lesions in the oral cavity in patients previously diagnosed with malignant lesions in distant tissues and 
organs.




Metastatic tumors of the oral cavity are uncommon, 
accounting for only 1% of all oral malignancies (1,2). 
These tumors, however, are of great clinical significan-
ce, since they may represent the first evidence of the dis-
semination of another (previously unknown) tumor from 
its primary site, or the first evidence of dissemination of 
a known tumor from its primary site (3). These lesions 
may occur in the oral soft tissues, in the jawbones or 
in both osseous and soft tissue. When it occurs in the 
jawbones, the mandible is the most common location, 
with the molar area being the most frequently involved 
site. When it affects the oral soft tissues, the attached 
gingiva is the most affected site (4). Any malignant tu-
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mor can metastasize to the oral cavity. Such lesions are 
most commonly found in males, primarily with lung, fo-
llowed by prostate, kidney, bone and adrenal malignan-
cies, and in females with breast followed by genital and 
thyroid malignancies (4,5). There are few case reports of 
metastasis to the oral cavity from relatively uncommon 
sites such as esophagus and liver (2,6). 
Metastatic solid tumors to the oral cavity are highly indi-
cative of a widespread disease process and can obvious-
ly modify the prognosis and treatment strategy. In addi-
tion, this condition is associated with poor survival rates, 
with survival time after oral metastasis diagnosis at 3.7 
to 8.25 months (5,7,8).  Most patients who present with 
a metastatic lesion in the oral cavity have already been 
diagnosed with primary tumors; however, in 23%–30% 
of cases, oral metastasis is the first manifestation of an 
undiscovered primary malignancy (4,7,8). 
Clinically, the metastatic lesions in the oral cavity mimic 
both benign and malignant lesions, making the diagnosis 
challenging and interesting. Benign or inflammatory le-
sions, which enter into the differential diagnoses, inclu-
de pyogenic granuloma, peripheral giant cell granuloma, 
peripheral ossify fibroma, and vascular anomaly. On the 
other hand, the differential diagnoses for malignant le-
sions include squamous cell carcinoma, lymphoma, soft 
tissue sarcoma and salivary gland carcinoma (1,8).
In this article, we report two new cases of metastatic tu-
mor of oral soft tissue and their clinical features and ma-
nagement, highlighting the importance to the clinicians 
of the possibility of metastatic lesion in the oral cavity 




In February 2015, a 55-year-old male was referred to the 
Oncologic Dentistry Service with the chief complaint of 
gingival bleeding and dental mobility. He reported that 
this complaint had begun five months previously with 
the appearance of a “lump” in the gingiva. The patient 
denied any odontogenic symptoms prior to the appea-
rance of the gingival bleeding and dental mobility. The 
patient reported being an ex-smoker and ex-alcoholic. 
The patient’s past medical history was significant for 
adenocarcinoma of the lung (cT4cN2Mx – IIIB). The 
tumor was unresectable by invasion of the pulmonary 
artery, and therefore the treatment plan was radiotherapy 
and chemotherapy. The physical examination revealed 
a mobile nodule approximately 1 cm in greatest diame-
ter, subcutaneously, in the right parotid region. Intraoral 
examination showed an exophytic tissue mass, with a 
smooth and lobulated surface, firm consistency, and a 
reddish-pink color located in the gingiva around teeth 
32, 31, 41, 42, 43 and 44. The tumor mass measured 6.0 
x 3.0 cm. The teeth presented accumulation of biofilm 
with gingival bleeding to the touch (Fig. 1A,B). Teeth 
41 and 42 showed grade 3 mobility. The imaging exams 
highlighted a radiolucent lytic lesion around teeth 41 
and 42. In view of the previous oncological diagnosis 
and the characteristics of the lesion, the hypothesis of a 
diagnosis of oral metastasis was considered.  The lesion 
was biopsied and the histology (Fig. 1C-F) and immuno-
histochemistry analysis of the mass revealed the lesion 
to be an adenocarcinoma of the lung (Fig. 2A-D) (Table 
1). The patient progressed with disease progression and 
respiratory failure, and one month later died.
-Case 2
In April 2016, a 61-year-old male was referred to the 
Oncologic Dentistry Service for evaluation of a gingival 
lesion to be clarified. The patient complained of dental 
mobility and gingival swelling for approximately the 
past 15 days. He had local discomfort and hypoesthesia 
on the lower lip on the right. The patient reported being a 
former smoker and ex-alcoholic. The patient’s past me-
dical history revealed an oropharyngeal cancer treated in 
2013 and a squamous cell carcinoma of the esophagus 
(T3NXM1 - IV) with cerebral metastasis in 2016. He 
was submitted to radiotherapy directed to the region of 
supraclavicular fossas, cervico-thoracic and esophageal 
concomitant to chemotherapy (Al-Sarraf Protocol). He 
was also submitted to stereotactic cranial radiosurgery 
covering two metastatic targets. Were administered sin-
gle doses of 1.500 cGy to the right subcortical parietal 
lesion and 800 cGy to the right fronto-parietal region 
near the convexity, respectively. Intraoral examination 
showed a firm consistency swelling overlapped by mu-
cosa with telangiectasias, located in the region of teeth 
43, 44 and 45, extending to the posterior region of the 
mandible. The lesion extended to the buccal and lin-
gual surfaces of the abovementioned teeth, measuring 
approximately 5.0 x 2.0 cm (Fig. 3A). Teeth 43, 44 and 
45 showed marked mobility. On the panoramic radio-
graph, there was a radiolucent lesion with irregular “mo-
th-eaten” borders, involving the roots of teeth 43, 44 and 
45, extending to the posterior region of the mandible on 
the right (Fig. 3B). In view of the previous oncologi-
cal diagnosis and the characteristics of the lesion, the 
diagnostic hypothesis of oral esophageal metastasis was 
raised. The lesion was biopsied and histologic and im-
munohistochemistry examination showed a moderately 
differentiated squamous cell carcinoma confirming the 
diagnostic hypothesis (Fig. 3C-F) (Table 1). The patient 
progressed with disease progression and one month later 
died.
Discussion
Invasion and metastasis are the most important causes of 
cancer-related morbidity and mortality and are the biolo-
gical hallmarks of malignant tumors. Although millions 
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Fig. 1: Metastasis of adenocarcinoma from lung to mandible. A: Clinical aspect of the lesion. B: 
Multinodular enlargements of mandible. C, D and E: Microscopic aspects of the lesion showing an 
adenocarcinoma with prominent duct-forming structures and large amounts of mucin through the 
epithelial proliferations. F: PAS stain after diastase digestion highlighted the mucin.
Fig. 2: Immunohistochemical features of the lesion. A: HE stain in low magnification. 
B: Positivity for CK-7. C: Negativity for CK-20. D: Thyroid transcription factor-1 (TTF1) 
positivity in most of the nuclei of the neoplastic cells.
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Fig. 3: Metastasis of esophageal carcinoma to mandible. A: Clinical aspect of the volumetric increase of the 
mandible on the right. B: Osteolytic lesion with poorly defined margins involving the right side of the anterior 
mandible. C: Microscopical aspects include epithelial malignant proliferations with variable amounts of kera-
tin, high atypia and pleomorphism cellular pleomorphism. D, E and F: Immunohistochemical features of the 
lesion include positivity for pan-Cytokeratin, AE1AE3, high number of Ki67-positive nuclei and high number 
of p16-positive nuclei, respectively.
Case Sex Age Diagnosis Primary site Immunohistochemistry
1 M 55 Adenocarcinoma lung TTF-1 (+), Ck7 (+), PAS (+),Ck20 (-), Ck14 (-), SMA (-), 
Ki67 (>50%).
2 M 61 Squamous
cell carcinoma
esophagus AE1AE3 (+), P16 (+), Ck19 (-), Ck7 (-), PAS (-), Ki67 
(>40%).
Table 1: Clinical data and results of immunohistochemical analyses.
of cells are released by the tumor into the circulation, 
very few of these cells are able to complete the metas-
tatic process (5,6). Metastasis to the oral cavity is extre-
mely rare and is associated with advanced stage, with 
a poor prognosis and short survival (1,4,6). However, 
because the maxillary bone is not routinely examined 
at necropsy, the true frequency may be higher (9). In 
the literature, there are more cases of metastasis to the 
jawbones than to oral soft tissues (1,10). However, as in 
the majority of the cases both the bone and the mucosa 
are affected, the first metastatic site may not always be 
apparent (11). The clinical presentation of oral metasta-
sis may vary from local swelling or pain to paresthesia 
and numbness (2,11). Here we describe two cases of me-
tastasis to the oral soft tissue (cavity) originating from 
the lung and esophagus presenting advanced stage and 
evolution to death within one month after the diagnosis 
of metastasis in the mouth.
Lung cancer, one of the most prevalent conditions in 
the world, is the most frequent cause of cancer-related 
death worldwide, and smoking is the predominant risk 
factor (11-13). Moreover, the lung is the most common 
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source for metastasis to the oral soft tissues in men, 
and the attached gingiva is the most common affec-
ted site followed by the tongue (1,6,8). Allon et al. 
showed that the gingiva that is prone to inflammation 
may serve as a pre-metastatic niche for the attraction 
of circulating malignant cells (5). Histologically, the 
primary foci of lung cancer are usually carcinomas, 
and among them adenocarcinomas are more common 
(2). In the 49 cases reviewed by Irani et al., the range 
of age of the patients at diagnosis with oral metastasis 
was 45 to 78 years, the time intervals from lung can-
cer to diagnosis of oral metastasis was one month to 
five years, the range of time duration of development 
of a metastatic lesion was one week to three years, 
and the time intervals from diagnosis to death were 
two weeks to 26 months (2). The age of the patient 
in Case 1 was 55 years and the initial detection time 
of the primary lung carcinoma and diagnosis of the 
oral metastasis was one month as was the death after 
diagnosis of metastasis in the mouth. The metastatic 
lesion appeared one month after the diagnosis of the 
primary tumor. Gingival bleeding and dental mobility 
presented by the patient are common clinical presen-
tation of oral metastasis (2,11). 
Esophageal cancer is one of most aggressive cancers. 
Expressive part of the cases spread to the head and neck 
region and are designated as stage IV (14). Most cases 
affect men between the ages of 30 and 69 years, with the 
lower gingiva, the tongue and the floor of the mouth be-
ing the most affected sites. Adenocarcinoma represents 
the most prevalent histological type (2,5,12). The time 
intervals from esophageal cancer detection to diagnosis 
of oral metastasis is between one month and seven years, 
the range of time duration for the development of me-
tastatic oral lesion is one to four months and the time 
intervals from diagnosis to death is one to four months 
(2). The age of our patient in Case 2 was 61 years, the 
initial detection time of the primary esophageal carcino-
ma and diagnosis of the oral metastasis was four months 
and the death after diagnosis of metastasis in the mou-
th was one month. The patient’s smoking history, along 
with advancing age would be major risk factors for the 
development of carcinoma (12,13). It is important to 
note that rapid swelling, pain and paresthesia can be car-
dinal symptoms of oral metastasis (2,4), as in our case 
where the patient also presented with hypoesthesia on 
the lower lip on the right. Advances in the treatment of 
cerebral metastasis through stereotactic radiosurgery, in 
addition to new classes of chemotherapy, target drugs 
and immunotherapy, are responsible for an average in-
crease of two to three times in the survival of patients 
with brain metastasis during the past decade. The greater 
survival length achieved by patients with metastatic di-
sease may be contributing to new patterns of recurrence, 
as observed in the case described (15). Our case, althou-
gh unusual, corroborates the literature regarding the ag-
gressive nature of esophageal cancer.
Clinically the two lesions presented evidence of an in-
crease in volume which is well reported in the litera-
ture as a relatively common pattern in oral metastasis. 
However, such characteristics should alert dentists, as 
well as general physicians, to the possibility of there be-
ing a metastatic oral disease, especially in patients with 
known malignant disease. Thus, metastatic tumors in 
the oral cavity are always challenging to diagnose and 
these lesions can mimic inflammatory and reactive le-
sions, which are common in the oral cavity, and other 
tumors should be considered in the differential diagno-
sis. It should be noted that the microscopic and immuno-
histochemical patterns of oral lesions are important for 
proper diagnosis.
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